MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lungcan.2020.05.023

Медицинская библиотека · Lung cancer (Amsterdam, Netherlands) · 2020

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.

Otsuka Kenji, Mitsuhashi Atsushi, Goto Hisatsugu, Hanibuchi Masaki, Koyama Kazuya, Ogawa Hirohisa, Ogino Hirokazu, Saijo Atsuro, Kozai Hiroyuki, Yoneda Hiroto, Tobiume Makoto, Kishuku Masatoshi, Ishizawa Keisuke, Nishioka Yasuhiko

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The combination of anti-PD-1/PD-L1 antibody with chemotherapy has been approved for the first-line therapy of lung cancer. However, the effects against malignant mesothelioma (MPM) and the immunological mechanisms by which chemotherapy enhances the effect of targeting PD-1/PD-L1 in MPM are poorly understood.

MATERIALS AND

METHODS

We utilized syngeneic mouse models of MPM and lung cancer and assessed the therapeutic effects of anti-PD-1 antibody and its combination with cisplatin (CDDP) and pemetrexed (PEM). An immunological analysis of tumor-infiltrating cells was performed with immunohistochemistry.

RESULTS

We observed significant therapeutic effects of anti-PD-1 antibody against MPM. Although the effect was associated with CD8+ and CD4+ T cells in tumors, the number of Foxp3+ cells was not reduced but rather increased. Consequently, combination with CDDP/PEM significantly enhanced the antitumor effects of anti-PD-1 antibody by decreasing numbers of intratumoral myeloid-derived suppressor cells (MDSCs) and vessels probably through suppression of VEGF expression by CDDP + PEM.

CONCLUSIONS

The combination of anti-PD-1 antibody with CDDP + PEM may be a promising therapy for MPM via inhibiting the accumulation of MDSCs and vessels in tumors.

Для цитирования: Otsuka Kenji, Mitsuhashi Atsushi, Goto Hisatsugu, Hanibuchi Masaki, Koyama Kazuya, Ogawa Hirohisa, Ogino Hirokazu, Saijo Atsuro, Kozai Hiroyuki, Yoneda Hiroto, Tobiume Makoto, Kishuku Masatoshi, Ishizawa Keisuke, Nishioka Yasuhiko. Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.. Lung cancer (Amsterdam, Netherlands). 2020. DOI: 10.1016/j.lungcan.2020.05.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.